ArticlePLoS neglected tropical diseases2026
Surveillance data and progress assessment of the targets of the WHO Global Leprosy Strategy 2016-2020: A retrospective registry-based analysis in Ghana.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe WHO Global Leprosy Strategy 2016-2020 aimed at early detection of new leprosy cases, reduction of grade-2 disabilities (G2D), and stopping any discrimination of people afflicted with leprosy while pointing out the importance of leprosy control programmes. In this retrospective study, data obtained from the Ghanaian National Leprosy Control Programme (NLCP) prior to the Covid-19 pandemic were analysed and compared with the key targets of the Global Leprosy Strategy 2016-2020. METHODOLOGY/PRINCIPAL
findingsDemographic as well as clinical data from the registry of the Ghanaian NLCP from 2017 to 2019 were reviewed and described. Evaluated targets and indicators for WHO programme monitoring included new case detection rates, proportion of new cases with G2D, biological sex, paediatric cases, proportions of multibacillary (MB) and paucibacillary (PB) cases and treatment completion rates. Data were further categorized according to region and year. A total of 816 new leprosy cases were evaluated in this analysis. Of these, 358 (43.9%) were female cases and 33 (4. 0%) were paediatric cases. While the annual new case detection rate per 100,000 population in Ghana was 0.86 in 2017, 0.93 in 2018, and 0.90 in 2019, individual regions, particularly the Upper West Region, remained consistently above the threshold of 1 new case per 100,000 (4.32, 4.71, 6.12). Of all new cases, 7.6% (n = 62) presented with G2D, the rate remained <1 per million population in each of the three years. One paediatric G2D case was reported in 2019. Annual treatment completion rates of MB and PB cases were well over 90% in 2017 and 2018. CONCLUSIONS/SIGNIFICANCE: The NLCP made partial progress towards the WHO targets. While the analysis demonstrates that Ghana was on track regarding the elimination of leprosy, the presence of one paediatric case with G2D at diagnosis highlights the need for continued targeted interventions and enhanced surveillance to achieve elimination goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.